Found this interesting and why Lepu maybe jumped in on a side deal...
“Merck and Viralytics anticipate the transaction will be implemented by the second quarter of 2018.
Additionally, the company has also invested $47mn to construct a new manufacturing and distribution platform in Asia, highlighting the increased demand for access to pharmaceutical products and solutions across the country.”
